FisherVista

SPARC AI Inc. was featured in a NetworkNewsAudio editorial discussing how its Overwatch software platform addresses the critical challenge of accurate navigation and targeting for drones in GPS-denied environments, highlighting the shift toward software-defined autonomy in defense technology.

MindBio Therapeutics is advancing AI-powered voice analysis technology to detect drug and alcohol intoxication in real-time, targeting industries like mining, aviation, construction, and law enforcement to enhance workplace safety.

H&H Forestry Ltd encourages customers to visit its yard to inspect oak timber firsthand before ordering, citing quality assurance and supply reliability amid rising demand for outdoor construction projects.

Frontieras North America Inc. is advancing a proprietary technology that converts coal into fuels, hydrogen, and industrial materials, targeting markets valued at over $2 trillion.

SureNano Science Ltd. is developing GEP-44, a patented triple agonist therapy targeting obesity and metabolic disorders, with preclinical data suggesting improved tolerability and potential non-injectable delivery.

Trilogy Metals Inc. announced that its Arctic Project in Alaska has been accepted as a FAST-41 Covered Project, a designation aimed at accelerating federal environmental review and permitting for critical mineral developments.

Oncotelic Therapeutics announced first-quarter 2026 financial results, highlighting progress in oncology, AI-enabled drug development, and advanced drug delivery initiatives.

5Gstore.com has announced eight years of zero shipping errors, highlighting its operational reliability in the connectivity hardware market.

McEwen Inc. announced that its portfolio company McEwen Copper has appointed Societe Generale to structure project debt financing for the Los Azules copper project, a move that could advance one of the world's first regenerative copper mines toward construction.

Safe Pro Group Inc. reported a 560% revenue increase to $1.22 million in Q1 2026, driven by commercialization of AI-powered drone imagery analysis for defense, signaling growing adoption of AI in battlefield situational awareness and explosive threat detection.

New RMI research reveals that wind and solar income is rivaling major farm commodities in some U.S. states, offering a financial lifeline to cash-strapped farming communities facing erratic weather and rising costs.

China's electric vehicle industry is under growing pressure from Western countries, reminiscent of U.S. restrictions on Japanese car exports in the 1980s, with implications for companies like NIO.

The release of the Senate's version of the CLARITY Act intensifies the regulatory debate over digital assets, with implications for industry players like Bit Digital Inc. and the broader crypto market.

A new study from Japan suggests that monitoring wastewater can forecast influenza outbreaks up to a week before clinical data, offering a crucial early warning tool for public health planning, especially in areas with limited diagnostic access.

Annovis Bio reported first-quarter 2026 progress including 85% enrollment in its pivotal Phase 3 Alzheimer’s trial and closure of enrollment to new participants, as it advances buntanetap toward potential regulatory submission.

Ford Motor Company announced its entry into the energy storage market, repurposing EV battery factory space, leading to its best daily stock rally in six years.

Toyota is shifting its strategy to embrace battery electric vehicles after years of focusing on hybrids, aiming to compete with China's dominant EV industry.

AI-focused companies have secured close to half of all venture capital deployed in Europe in 2026, highlighting the region's growing emphasis on artificial intelligence and its impact on the startup ecosystem.

Scientists have developed a new catalyst that may significantly reduce the cost of producing hydrogen from water, enhancing the viability of renewable energy storage systems.

NanoViricides' quarterly report details progress on NV-387, including regulatory approval for Phase II MPox trials in the DRC and FDA orphan drug designations, highlighting its potential as a broad-spectrum antiviral.

SOLOWIN HOLDINGS' AX Coin subsidiary signs a non-binding MOU with INFINIOS to develop regulated wallet infrastructure and digital payment solutions, aiming to accelerate stablecoin adoption across the Gulf region.